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Abstract
Previous dual task studies have demonstrated that patients with sporadic Alzheimer’s disease (AD) are impaired in their
ability to perform two tasks simultaneously compared with healthy controls, despite being able to successfully perform
the tasks alone relatively well. Yet, it remains unclear what the earliest clinical manifestation of this dual task coordination
deficit is. This study examined dual task abilities in individuals who are at risk of early-onset familial AD due to an E280A
presenilin-1 mutation. Thirty-nine carriers of the gene mutation who did not meet the criteria for AD and 29 non-carrier
healthy controls were asked to perform digit recall accompanied by a secondary tracking task. Individuals who were
carriers of the genetic mutation demonstrated significantly higher dual task costs than healthy non-carriers. Dual task
performance was found to be more sensitive to this very early stage of FAD than episodic memory measures. The findings
support the notion that a deficit in the coordination mechanism of the central executive may be a pre-clinical marker for the
early detection of AD due to the E280A presenilin-1 gene mutation. (JINS, 2012, 18, 234–241)
Keywords: Familial Alzheimer’s disease presenilin-1, Dual task, Working memory, Early diagnosis, Neuropsychological
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INTRODUCTION
Patients in the early stages of Alzheimer’s disease (AD) often
are impaired in the ability to perform two tasks simultaneously
despite being able to perform the tasks separately relatively
well (Baddeley, Bressi, Della Sala, Logie, & Spinnler, 1991;
Baddeley, Logie, Bressi, Della Sala, & Spinnler, 1986; Della
Sala, Cocchini, Logie, Allerhand, & MacPherson, 2010;
Holtzer, Burright, & Donovick, 2004; Logie, Cocchini, Della
Sala, & Baddeley, 2004; MacPherson, Della Sala, Logie,
& Wilcock, 2007; Sebastian, Menor, & Elosua, 2006). In
contrast, healthy younger and older adults are able to perform
the same tasks concurrently with very little decline in per-
formance on either task, suggesting that dual task deficits
are characteristic of AD but not healthy adult ageing (for a
discussion, see Logie, Della Sala, MacPherson, & Cooper,
2007; and Anderson, Bucks, Bayliss, & Della Sala, 2011).
This dual task decrement in AD patients is independent
from single tasks differences between patients and healthy
controls as each participant performs the tasks at their own
individual ability levels and therefore the groups are matched
in terms of single task performance. The dual task impair-
ment is also independent from overall cognitive demands,
as reducing the demands of the two single tasks does not
remove the dual task effect whilst increasing the demands has
similar effects on patients and healthy individuals (Logie
et al., 2004). Furthermore, the dual task impairment reported
in AD patients increases with disease progression (Baddeley
et al., 1991).
The ability of healthy individuals to perform particular
combinations of tasks at the same time has been explained in
terms of a multiple-component working memory system
(Baddeley, 1986; Baddeley & Logie, 1999). Each of the tasks
selected for the dual task paradigm is thought to draw upon
different peripheral systems: digit recall draws upon the
phonological loop, which provides the processing and tem-
porary storage of verbal information, and tracking taps the
visual-spatial scratch pad, which provides the processing and
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temporary storage of visual-spatial information. Providing
the tasks use these different peripheral systems, healthy
individuals show little interference performing the tasks
simultaneously. Although AD patients are able to perform
these tasks alone relatively well when performed at indivi-
dual ability levels, they are said to have a failure in the
mechanism of the central executive which coordinates the
operation of the different peripheral systems resulting in a
dual task decrement (Baddeley et al., 1986, 1991; Della Sala,
Baddeley, Papagno, & Spinnler, 1995; Greene, Hodges, &
Baddeley, 1995; Logie et al., 2004).
Patients with AD also perform poorly on episodic memory
tasks such as free recall, delayed recall and recognition memory
(e.g., Grady et al., 1988; Greene, Baddeley, & Hodges, 1996;
Welsh, Butters, Hughes, Mohs, & Heyman, 1991). However,
such impairments are also reported in healthy older adults,
and therefore while memory decline is highly predictive as an
early indicator of AD, it would be advantageous to include in
the assessment, a task that demonstrates specific AD-related
deficits which does not rely on quantitative differences between
AD and healthy ageing (Craik, 1994; Park et al., 1996; Park,
Lautenschlager, Hedden, Davidson, Smith, & Smith, 2002).
Furthermore, as AD progresses, episodic memory performance
reaches floor levels, making it difficult to monitor disease
progression (Largen, 1984; Spinnler & Della Sala, 1988;
Wicklund, Rademaker, Johnson, Weitner, & Weintraub, 2007).
As the dual task paradigm has the advantage of not demon-
strating effects of healthy adult ageing when the tasks are
titrated for individual ability, it can be used to assess and
follow-up individuals with AD in combination with episodic
memory measures.
Our previous work has examined dual task abilities in
patients with AD. Yet, the ability of individuals with a genetic
susceptibility to develop AD to perform the dual task paradigm
has not been investigated until now. They are an important
clinical group in determining which cognitive impairments
occur in the early stages of AD (Ringman et al., 2009). In
the current study, individuals with the E280A mutation in the
presenilin-1 gene were compared with non-carriers of the
mutation in terms of dual task performance in an attempt to
establish whether this paradigm could differentiate between
carriers and non-carriers of the genetic mutation. All indivi-
duals who carry this genetic mutation develop an autosomic
dominant familial Alzheimer’s disease which becomes clini-
cally evident around 48 years of age (see Lopera et al., 1997
for a clinical description of the disease). More recently, three
pre-dementia stages were identified in carriers of this mutation
at 35, 38, and 44 years of age (Acosta-Baena et al., 2011).
Lopera et al. (1997) reported that the E280A-related FAD
resembles sporadic AD in most of its clinical features. Yet, as
carriers of the E280A mutation have demonstrated cognitive
deficits as young as 40 years of age (Lopera et al., 1997), the
clinical manifestation of FAD may begin well before it meets
the standard criteria for the diagnosis of AD. The aim of
this study was to investigate whether carriers of the genetic
mutation who did not yet meet the criteria for AD would
demonstrate dual task impairments compared with non-carriers.
METHODS
Participants
Participants were recruited from a large extended family from
the province of Antioquia in Colombia, South America
enrolled in the FAD Research Program led by the Neuro-
science Group, at the University of Antioquia, Colombia.
Members of this family carry the single mutation E280A in
the preseniline-1 gene which leads to early-onset familial
Alzheimer’s disease in 100% of carriers (Lopera et al., 1997).
To confirm the presence of the gene mutation, participants
were genetically screened according to the methodology
reported by the Alzheimer’s Disease Collaborative Group
(1995) (see also Lemere et al., 1996; Lendon et al., 1997)
resulting in their categorization as individuals who were
carriers of the gene mutation or individuals who did not carry
the gene mutation. We were informed about the genetic status
after the participants had completed the assessment protocol
using an anonymous procedure. Hence, all the participants
that entered the study were blindly assessed. Thirty-nine
participants tested positive for the E280A mutation (carriers)
but had no memory or other cognitive complaints at the time
of testing. Indeed, they did not report any subjective com-
plaints of memory difficulties by means of a formal 15-item
Subjective Memory Complaints Checklist (Ardila et al., 2000)
where each of the participants and a close relative were asked
about the status of the participant’s memory. Twenty-nine
participants were negative for the E280A mutation (non-carrier
healthy control group). The carriers and non-carrier healthy
controls did not have any history of neurological or psychiatric
disorders and scoredZ24 on Mini-Mental State Examination
(MMSE; Folstein, Folstein, & McHugh, 1975).
The demographic characteristics of the carriers and non-
carrier healthy controls are shown in Table 1. The two groups
did not significantly differ in terms of age or the number of
years of full-time education. The carriers and non-carrier
healthy controls were matched for MMSE scores. In addition,
the two groups did not significantly differ in their scores on
the short form of the Yesavage Geriatric Depression Scale
(Yesavage, 1988), which was administered as a screening
measure for depression. The research was completed in
accordance with the Declaration of Helsinki.
Background Neuropsychological Measures
The neuropsychological battery included Spanish-language
versions (see Aguirre-Acevedo et al., 2007) of the Mini-
Mental State Examination (MMSE; Folstein et al., 1975),
verbal IQ from the Wechsler Adult Intelligence Scale – Third
Edition (WAIS-III; Wechsler, 1997), Raven’s Advanced
Progressive Matrices (Raven, 1982), Boston Naming Test
(Kaplan, Goodglass, & Weintraub, 1983), Arithmetic subtest
from the WAIS (Wechsler, 1981), FAS Verbal Fluency Test
(adapted from Sumerall, Timmons, James, Ewing, & Oehlert,
1997), the Modified Wisconsin Card Sorting Test (Nelson, 1976),
Part A of the Trail Making Test (Reitan & Wolfson, 1993)
and Cancellation As Test (Ardila, Rosselli, & Puente, 1994).
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The episodic memory measures included verbal learning
(Ardila et al., 1994), Paired Associates Learning Test
(Wechsler, 1945) and the Rey-Osterrieth Complex Figure Test
(Osterrieth, 1944; Rey, 1941).
Dual Task Paradigm
First, the digit span of each participant was assessed. Then
participants were asked to perform a digit recall task at span
and then the same digit recall task at span together with a
secondary tracking task.
Digit span
Participants were presented with lists of digits, recorded in
Spanish by a male speaker, at a rate of two digits per second.
After presentation of each list, participants were asked to
immediately recall the digits orally in the same order. Parti-
cipants were first presented with a sequence of two digits. If
two out of three sequences with two digits were correctly
recalled, the sequence length was increased by one digit. This
procedure of increasing the length of the sequences by one digit
continued until the participant was unable to serially recall at
least two out of three sequences at a given sequence length.
Digit span for each individual was taken as the maximum
sequence length at which an individual was able to remember
two out of three sequences correctly. There were no time limits
for recall.
Single digit recall
Participants were presented with a series of lists of digits for
a 90-s period. After each list, participants were asked to
immediately recall back the digits in the same order as they
had previously been presented. The sequence length for each
list was fixed for each individual according to their digit span
so while one participant might be presented with sequences
of 5 digits in length, another participant might be presented
with sequences of 6 digits in length. The number of digit
sequences presented to each participant within the 90-s period
differed, as those with longer spans could complete fewer digit
lists within the time period compared with those with shorter
digit spans. However, the participants were presented with a
similar number of digits overall. For example, an individual
with a span of 4 might be presented with 12 lists of digits,
totaling 48 digits, whereas an individual with a span of 5 might
be presented with 9 lists of digits, totaling 45 digits. There
were no time limits for recall. The dependent variable was the
percentage of correctly recalled digits in the correct position.
Dual digit recall
Participants performed the dual digit recall task in the same
way as the single digit recall task described above but this
time they performed the digit task together with a secondary
tracking task. Digit recall was performed at individual span.
The dependent variable for digit recall was accuracy.
Secondary tracking task
Participants were presented with a sheet of A3 paper which
contained a maze of boxes connected by arrows. Participants
were asked to place their pencils on the black area marked
start and then begin placing a cross in each successive box as
quickly as possible for 90 s. If participants managed to cross
all the boxes on the A3 sheet before the 90-s period was
complete, a second sheet was presented.
Statistical Analyses
When the data were normally distributed, the performance
of the carriers and healthy controls on the background mea-
sures was compared using an independent samples t test.
When the data were not normally distributed, nonparametric
Mann-Whitney U tests were conducted. For dual task digit
recall performance, a two-way mixed analysis of variance
(ANOVA) was conducted with group (carriers vs. healthy
controls) and task (single vs. dual) entered as factors. Post hoc
analysis was conducted using Bonferroni t tests.
The performance on tasks that significantly differentiated
between the two groups was then entered into a hierarchical
multiple regression models to determine the proportion of
variance that they could account for across groups. Finally,
those tests that explained the largest proportion of variance
across groups entered receiver operating characteristic (ROC)
analysis to determine their sensitivity and specificity.
RESULTS
Background neuropsychological measures
Table 2 shows the means and standard deviations for the
performance of the two groups on the background neuro-
psychological measures. The comparisons between groups
Table 1. Means and standard deviations in parentheses for the demographic characteristics of the participants
Carriers (n5 39) Non-carrier controls (n5 29) t p
Age 35.59 (6.0) 38.41 (8.4) 21.62 n.s.
Years of education 9.77 (4.0) 9.69 (3.9) 0.08 n.s.
Gender (male/female) 11/28 4/25
MMSE (max5 30) 29.28 (1.2) 29.21 (1.6) 0.22 n.s.
Yesavage Geriatric Depression Scale (max5 15) 1.47 (2.66) 1.93 (2.62) 20.70 n.s.
Digit Span 4.31 (0.8) 4.48 (0.6) 21.00 n.s.
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revealed that the carriers had significantly poorer memory
performance on verbal learning and paired associates than
the healthy controls. However, the two groups did not sig-
nificantly differ in terms of recall of the Rey-Osterrieth
Complex Figure. The performance of the carriers did not
significantly differ from the healthy controls on any of the
other background measures. Therefore, the standard neuro-
psychological assessment unveiled amnesic deficits which
had gone unnoticed by the carriers and their relatives.
Dual Task Paradigm
Table 1 shows the individual digit span means and standard
deviations for the carriers and non-carrier controls. An inde-
pendent samples t test revealed the carriers and controls did
not significantly differ in terms of digit span.
Dual Task Performance
The single and dual task digit recall performance of the
groups is shown in Table 3. The mixed ANOVA model
revealed a significant main effect of group, F(1,66)5 14.34;
p, .0001, hp
25 .18; condition, F(1,66)5 14.29; p, .0001;
hp
25 .18 and a significant two-way interaction,F(1,66)55.65;
p, .05, hp
25 .08. Post hoc Bonferroni analysis revealed
that the two groups did not significantly differ in terms of
single task performance thus confirming that both groups
performed the task at their own capacity. In terms of dual task
performance, the carriers performed significantly more
poorly than the controls (p, .0001). Moreover, the carriers
showed a significant dual task drop in terms of digit recall
performance from single to dual task conditions (p, .0001),
whereas the non-carrier controls did not.
To ascertain the incremental variance associated with
including dual task digit recall, verbal learning delayed recall
and paired associates learning recall when identifying group
differences, performance on these tasks was entered into a
hierarchical multiple regression models using the enter method
(see Table 4). For the carriers, dual digit recall explained
19.6% of the variance. When verbal learning delayed recall
was added to the model, it explained an additional 9.4% of the
variance. When both verbal learning delayed recall and paired
associates learning recall were added to the model, it explained
an additional 5.1% of the variance but verbal learning delayed
recall was not a significant predictor. Therefore, the final
model which includes dual digit recall and paired associates
Table 2. Means and standard deviations in parentheses for the background measures performed by the carriers and non-carrier controls
Carriers (n5 39) Non-carrier controls (n5 29) Test statistic p
Verbal Learning
Maximum Length (max5 10) 8.95 (1.3) 10.00 (0) 304.50# ,.0001
Number of Lists (max5 10) 7.56 (2.7) 4.41 (1.5) 6.15* ,.0001
Delayed Recall (max5 10) 4.49 (1.4) 5.69 (0.9) 24.19* ,.0001
Paired Associates
Total correct (max5 24) 11.87 (4.2) 16.26 (2.3) 25.56* ,.0001
Learning Recall Difficult Items (max5 8) 4.46 (3.2) 7.86 (2.0) 25.30* ,.0001
Rey-Osterrieth Complex Figure Immediate Recall (max5 36) 14.14 (6.9) 14.48 (6.2) 2.21* n.s.
WAIS Verbal IQ 87.82 (11.5) 92.2 (14.2) 21.41* n.s.
Raven’s APM Part A (max5 12) 9.23 (2.0) 8.83 (2.1) 498.50# n.s.
Boston Naming (max5 15) 13.15 (1.7) 13.48 (1.2) 535.50# n.s.
WAIS Arithmetic (max5 10) 8.56 (1.6) 8.41 (1.6) 531.50# n.s.
Verbal Fluency 11.56 (5.3) 10.93 (3.6) 0.55* n.s.
M-WCST
Errors 21.05 (7.3) 22.79 (8.6) 20.89* n.s.
Perseverative Errors 13.37 (6.0) 15.72 (7.6) 21.42* n.s.
Conceptual 11.05 (7.5) 12.76 (7.3) 20.92* n.s.
Categories (max5 6) 3.32 (1.4) 3.17 (1.5) 509.00# n.s.
Trail Making Part A
Errors (max5 24) 0.11 (0.4) 0.14 (0.6) 531.00# n.s.
Time (seconds) 69.36 (49.0) 69.90 (41.2) 20.05* n.s.
Cancellation As
Omissions 0.26 (0.6) 0.62 (1.9) 531.00# n.s.
Time (seconds) 36.47 (16.1) 38.00 (16.0) 20.39* n.s.
WAIS5Wechsler Adult Intelligence Scale; APM5Advanced Progressive Matrices; M-WCST5Modified Wisconsin Card Sorting Test; *5 Independent
Samples T-test; #5Mann-Whitney U-Test.
Table 3. Mean percentage correct across trials on single task
and dual task digit recall performance with standard deviations in
parentheses for the two groups
Carriers (n5 39) Non-carrier controls (n5 29)
Single task 90.78 (8.56) 94.99 (7.1)
Dual task 83.24 (12.14) 93.27 (6.7)
Dual task in familial AD 237
learning recall as predictors significantly improves the ability
to predict the proportion of variance between carriers and
non-carrier controls.
The carriers recruited for the study did not report any
memory or other cognitive complaints. Yet, formal neuro-
psychological assessment revealed that some presented with
episodic memory impairments. It was therefore necessary to
investigate the classification power of the measures that
explained the largest proportion of variance across the
carriers with and without episodic memory impairments at
the individual level. The carriers were classified as sympto-
matic (n5 20) if they scored more than 1 SD below the mean
of the 29 non-carrier controls on verbal learning delayed
recall (mean5 5.69; SD5 0.93) and asymptomatic (n5 19)
if they scored less than 1 SD from the non-carrier control
mean. This was based on the recent recommendations
from the National Institute on Aging and Alzheimer’s Asso-
ciation workgroup who suggest that individuals with MCI
typically perform 1 to 1.5 SD below the mean for age- and
education-matched controls (Albert et al., 2011). Area under
the curve analysis was then carried out to investigate whether
performance on the episodic memory tasks and dual task digit
recall was able to classify individuals into these different
groups correctly. Table 5 demonstrates the results of this
analysis. For the carriers without memory impairments, this
procedure resulted in a dramatic drop in the classification
power of the memory tests but not of the dual tasking mea-
sure, which provided 68% sensitivity and 72% specificity for
conversion to FAD.
DISCUSSION
Previous studies of dual task performance have demonstrated
that patients in the early stages of AD show significant dual
task impairments (Baddeley et al., 1986, 1991; Della Sala et al.,
2010; MacPherson et al., 2007). In the current experiment,
individuals who were carriers of the E280A presenilin-1
mutation but did not meet the criteria for AD showed
significant dual task decrements compared with healthy
non-carrier controls. Further analysis revealed that dual task
performance and paired associated learning recall explained
the largest proportion of the variance between the carriers
Table 4. Regression model for the carriers versus the non-carrier controls on the digit recall and memory measures
Predictor variables R R2 Adjusted R2 R2 Change F(p)
DD only 0.443 0.196 0.184 0.196 16.08 (,.0001)
DD and VL 0.538 0.290 0.268 0.094 13.25 (,.0001)
DD, VL and PA 0.583 0.340 0.309 0.051 11.01 (,.0001)
DD5Dual Digit; VL5Verbal Learning Delayed Recall; PA5Paired Associates Learning.
Table 5. ROC analysis with the dual digit and episodic memory variables that explained the largest proportion of the variance across groups
All carriers vs. Non-carrier
controls (n5 39)
Carriers with memory
impairment vs. Non-carrier
controls (n5 20)
Carriers without memory
impairment vs. Non-carrier
controls (n5 19)
Dual Digit
Criterion .93.18 <86.36 <93.18
Sensitivity 72.41 75.00 68.42
Specificity 76.92 82.76 72.41
AUC (p) 0.76 (,.001) 0.85 (,.001) 0.67 (,.05)
PPV 78.9 75.0 61.9
NPV 70.0 82.8 77.8
Verbal Learning Delayed Recall
Criterion .4 <4 <5
Sensitivity 89.66 100 53.63
Specificity 51.28 89.66 58.62
AUC (p) 0.76 (,.001) 0.97 (,.001) 0.51 (n.s.)
PPV 87.0 87.0 45.5
NPV 57.8 100.0 65.4
Paired Associates Learning Recall Difficult Items
Criterion <6 <3 <6
Sensitivity 74.4 85.0 47.4
Specificity 75.9 93.1 75.9
AUC (p) 0.80 (,.001) 0.99 (,.001) 0.62 (n.s.)
PPV 80.6 90.5 58.8
NPV 68.8 96.4 71.0
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and controls. These findings suggest that deterioration in the
dual task co-ordination mechanism characterizes E280A-
related familial AD in its very early stages.
Although the carriers reported no memory complaints as
documented by a self-report and family questionnaire, some
individuals did show episodic memory impairments when
assessed clinically. Therefore, the carriers were subdivided
into those individuals with episodic memory impairments
and those without, and area under the curve analysis was
conducted. The analysis revealed that splitting carriers
according to the presence or absence of memory impairments
greatly impacted on the classification power of these standard
memory tests (something that is expected from this mani-
pulation) but did not modify the classification power of the
dual task variable to the same extent. Therefore, when only
the asymptomatic carriers were compared with the non-
carriers, that is, individuals who have memory impairments
are removed from the analysis, the dual task digit recall
combines acceptable levels of sensitivity (68%) and specifi-
city (72%) for carriers who are asymptomatic based on
subjective and objective cognitive measures, and yet will go
on to develop FAD (see the final column of Table 5). These
findings suggest that dual task digit recall performance might
be a preclinical marker of AD whereas performance on verbal
learning tasks appears to be an early clinical marker of the
disease. Taken together, the results presented here suggest
that combining these two tasks in the assessment both the
preclinical and early clinical characteristics of the disease
could be captured, reducing by this means false positives and
false negatives.
The dual task costs reported in the carriers do not appear to
be related to their performance on the background neuro-
psychological measures included in this study. The carriers
only significantly differed in their performance on the epi-
sodic memory measures compared with controls and not on
the measures of IQ, executive function or speed of proces-
sing. Moreover, the carriers were matched in terms of MMSE
scores with the healthy non-carrier controls. This is in line
with our previous work with sporadic AD patients which
has also shown that dual task performance is not influenced
by MMSE scores, for example, MacPherson et al. (2007).
However, performance on other neuropsychological mea-
sures and their association with dual task performance in our
sporadic AD patients has not typically been examined.
It could be argued that the dual task deficits reported in AD
patients (and some ageing studies) is simply a consequence
of a generalized, diminished cognitive processing resource,
that is, speed of processing, rather than an impairment in a
specific mechanism responsible for co-ordinating the perfor-
mance of two tasks at the same time. However, in the current
study, the carrier and non-carrier groups did not significantly
differ in their speed of processing abilities which were
assessed using the Trail Making Test Part A and Cancellation
As. This suggests that the dual task deficit in our carrier group
was not simply due to slower processing speed. Although this
evidence is post hoc, speed of processing differences between
AD patient and control groups performing the dual task
paradigm does merit further investigation, to add to our
confidence that the AD-related dual task effects are not simply
due to difficulties in switching between tasks due to slower
speed of processing.
Lopera et al. (1997) propose that E280A familial AD is
similar to late-onset sporadic AD in terms of the majority of
its characteristics. Therefore, it could be argued that our
asymptomatic carriers are at the equivalent stage in their
disease progression as individuals with pre-mild cognitive
impairment. As some of these individuals will eventually
convert to sporadic AD, dual tasking may be useful for
detecting cognitive changes in this vulnerable group. Some
previous studies of dual task abilities in mild cognitive
impairment (MCI) in sporadic AD have reported significant
dual task decrements compared with healthy controls
(Dannhauser et al., 2005; Holtzer et al., 2004; Ritchie, Artero,
& Touchon, 2001), yet others have not (Lopez et al., 2006;
Nordlund et al., 2005; Pettersson, Olsson, & Wahlund,
2005). Our recent work using a similar dual-task paradigm
did not find a significant difference between individuals with
MCI and a healthy control group (Foley, Kaschel, Logie, &
Della Sala, 2011). However, the MCI group were variable in
their dual task performance and Foley et al. (2011) suggest
that the MCI individuals who perform dual tasking well may
have stable deficits longitudinally, while those who perform
dual tasking poorly will be more likely to convert to AD
(see also Robert et al., 2006). Another explanation for the
different findings in the current study and our previous work
(Foley et al., 2011) may be that the dual-task deficit demon-
strated in our FAD patients is associated with the E280A
mutation in the presenilin-1 gene rather than an early AD-
related dual-task deficit. Indeed, other studies suggest that
there may be phenotypic differences between genetic and
sporadic AD (Holmes, 2002; Mosconi et al., 2003).
There may be other confounds which contribute to the poor
performance of our asymptomatic carriers on dual tasking
such as depression or test anxiety. Although the participants
were blind to their status, it may be that the asymptomatic
carriers suffer from low or depressed mood. However, in this
study, our carriers and non-carrier controls did not sig-
nificantly differ in terms of their level of depression. Moreover,
our previous work has shown that individuals with chronic
depression do not show dual task deficits. Of interest, this
remains the case even when the chronically depressed indi-
viduals were matched for episodic memory performance with
AD patients (Kaschel, Logie, Kazen, Della Sala, 2009). The
issue of test anxiety may also affect dual task performance.
However, the asymptomatic carriers and non-carrier controls
were drawn from the same rural community and were sub-
jected to the equivalent longitudinal neuropsychological
assessment, and so test anxiety is likely to have affected the
two groups in a similar manner.
In summary, the current findings provide evidence that
carriers of the E280A genetic mutation show a specific
impairment in performing two tasks simultaneously. These
carriers performed as well as non-carrier controls on all
background neuropsychological tests except the episodic
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memory measures, suggesting that dual task impairments are a
fundamental characteristic of AD and may be an early indi-
cator for the diagnosis of E280A familial Alzheimer’s disease
in genetic carriers. The results also showed that dual task
performance identifies asymptomatic carriers better and earlier
than episodic memory tasks. Remarkably, unlike episodic
memory measures, dual tasking has the additional advantage
that impairments do not occur in healthy adult ageing.
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